I think we have to get much further along before an offer of either of those amounts would be made. The issue, as I have said many times is that as we progress and our value grows, we will price ourselves out of a buyout. Which is good.

To be clear, and to satiate those that are irritated with the high projections, I don't think COVID gets us that high unless we become the standard of care worldwide and the pandemic appears to have a long life.

But, if things fall in our direction and in a few months our share price is $20+, then these valuations become more likely.